Friday, February 12, 2016 Last update: 6:03 AM
FreshNews.com - Covering Large & Obscure Tech Companies Since 1996

NanoViricides, Inc.

News articles for NanoViricides, Inc.:

Thursday, February 11, 2016

Wednesday, February 10, 2016

  • NanoViricides Files Quarterly Report for Period Ending 2015-12-31
    SHELTON, Conn., Feb. 10, 2016 /PRNewswire/ -- NanoViricides, Inc. (NYSE MKT: NNVC) (the "Company"), filed its quarterly report in a timely manner with the Securities and Exchange Commission on Tuesday, February 9th. The submission can be downloaded from the SEC website at http://www.sec.gov/Archives/edgar/data/1379006/000114420416079966/v429785_10q.htm. https://photos.prnewswire.com/prnvar/20150107/167444LOGO NanoViricides reported that ... read more

Monday, February 8, 2016

Monday, February 1, 2016

Monday, January 25, 2016

Tuesday, January 12, 2016

Tuesday, November 10, 2015

  • NanoViricides Files Quarterly Report for Period Ending 2015-09-30
    SHELTON, Conn., Nov. 10, 2015 /PRNewswire/ -- NanoViricides, Inc. (NYSE MKT: NNVC) (the "Company"), filed its quarterly report in a timely manner with the Securities and Exchange Commission on Monday, November 9th. The submission can be downloaded from the SEC website at http://www.sec.gov/Archives/edgar/data/1379006/000114420415063679/v422773_10q.htm. http://photos.prnewswire.com/prnvar/20150107/167444LOGO The Company estimates ... read more

Wednesday, September 16, 2015

  • NanoViricides Files Annual Report
    WEST HAVEN, Conn., Sept. 16, 2015 /PRNewswire/ -- NanoViricides, Inc. (NYSE MKT: NNVC) (the "Company"), reports that it has filed its financial year end annual report (Form 10-K) with the Securities and Exchange Commission (SEC) on Monday, September 14, 2015 in a timely manner. The report can ... read more

Monday, August 17, 2015

  • NanoViricides Accelerates its Herpes Drug Development Program
    SHELTON, Conn., Aug. 17, 2015 /PRNewswire/ -- NanoViricides, Inc., (NYSE MKT: NNVC) (the "Company"), a nanomedicine company developing anti-viral drugs, reports that it is accelerating its HerpeCide(TM) drug development program. http://photos.prnewswire.com/prnvar/20150107/167444LOGO The Company will continue to develop its anti-herpesvirus franchise in parallel with the development of FluCide(TM), its anti-influenza ... read more